Sato A - Search Results

1

Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine.

Isono M, Hoffmann MJ, Pinkerneil M, Sato A, Michaelis M, Cinatl J Jr, Niegisch G, Schulz WA. Isono M, et al. Among authors: sato a. J Exp Clin Cancer Res. 2017 Jan 3;36(1):1. doi: 10.1186/s13046-016-0473-1. J Exp Clin Cancer Res. 2017. PMID: 28049532 Free PMC article.

2

Inhibition of checkpoint kinase 1 potentiates anticancer activity of gemcitabine in bladder cancer cells.

Isono M, Okubo K, Asano T, Sato A. Isono M, et al. Among authors: sato a. Sci Rep. 2021 May 13;11(1):10181. doi: 10.1038/s41598-021-89684-5. Sci Rep. 2021. PMID: 33986399 Free PMC article.

3

Ritonavir and ixazomib kill bladder cancer cells by causing ubiquitinated protein accumulation.

Sato A, Asano T, Okubo K, Isono M, Asano T. Sato A, et al. Cancer Sci. 2017 Jun;108(6):1194-1202. doi: 10.1111/cas.13242. Epub 2017 May 20. Cancer Sci. 2017. PMID: 28342223 Free PMC article.

4

Fluvastatin potentiates anticancer activity of vorinostat in renal cancer cells.

Okubo K, Isono M, Miyai K, Asano T, Sato A. Okubo K, et al. Among authors: sato a. Cancer Sci. 2020 Jan;111(1):112-126. doi: 10.1111/cas.14225. Epub 2019 Nov 25. Cancer Sci. 2020. PMID: 31675763 Free PMC article.

5

Nelfinavir and Ritonavir Kill Bladder Cancer Cells Synergistically by Inducing Endoplasmic Reticulum Stress.

Sato A, Asano T, Okubo K, Isono M, Asano T. Sato A, et al. Oncol Res. 2018 Mar 5;26(2):323-332. doi: 10.3727/096504017X14957929842972. Epub 2017 May 26. Oncol Res. 2018. PMID: 28560953 Free PMC article.

6

Delanzomib Interacts with Ritonavir Synergistically to Cause Endoplasmic Reticulum Stress in Renal Cancer Cells.

Isono M, Sato A, Asano T, Okubo K, Asano T. Isono M, et al. Among authors: sato a. Anticancer Res. 2018 Jun;38(6):3493-3500. doi: 10.21873/anticanres.12620. Anticancer Res. 2018. PMID: 29848702

7

Evaluation of Therapeutic Potential of Phenoxodiol, a Novel Isoflavone Analog, in Renal Cancer Cells.

Isono M, Sato A, Asano T, Okubo K, Asano T. Isono M, et al. Among authors: sato a. Anticancer Res. 2018 Oct;38(10):5709-5716. doi: 10.21873/anticanres.12908. Anticancer Res. 2018. PMID: 30275191

8

Ubiquitin-proteasome System Is a Promising Target for Killing Cisplatin-resistant Bladder Cancer Cells.

Okubo K, Isono M, Asano T, REßING N, Schulz WA, Hansen FK, Sato A. Okubo K, et al. Among authors: sato a. Anticancer Res. 2021 Jun;41(6):2901-2912. doi: 10.21873/anticanres.15072. Anticancer Res. 2021. PMID: 34083281

9

The Dual Histone Deacetylase-Proteasome Inhibitor RTS-V5 Acts Synergistically With Ritonavir to Induce Endoplasmic Reticulum Stress in Bladder Cancer Cells.

Okubo K, REßING N, Schulz WA, Hansen FK, Asano T, Sato A. Okubo K, et al. Among authors: sato a. Anticancer Res. 2021 Dec;41(12):5987-5996. doi: 10.21873/anticanres.15417. Anticancer Res. 2021. PMID: 34848452

10

Ataxia telangiectasia and Rad3-related inhibition by AZD6738 enhances gemcitabine-induced cytotoxic effects in bladder cancer cells.

Isono M, Okubo K, Asano T, Sato A. Isono M, et al. Among authors: sato a. PLoS One. 2022 Apr 12;17(4):e0266476. doi: 10.1371/journal.pone.0266476. eCollection 2022. PLoS One. 2022. PMID: 35413091 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,457 results

Search Page

Filters